Detalles de la búsqueda
1.
Effectiveness, safety, and healthcare costs associated with rivaroxaban versus warfarin among venous thromboembolism patients with obesity: a real-world study in the United States.
J Thromb Thrombolysis
; 54(3): 438-448, 2022 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-35562510
2.
Effectiveness and safety of rivaroxaban versus warfarin in obese patients with acute venous thromboembolism: analysis of electronic health record data.
J Thromb Thrombolysis
; 51(2): 349-358, 2021 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-32588288
3.
Rivaroxaban versus warfarin in patients with nonvalvular atrial fibrillation and stage IV-V chronic kidney disease.
Am Heart J
; 223: 3-11, 2020 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-32112872
4.
Rivaroxaban versus warfarin for treatment and prevention of recurrence of venous thromboembolism in African American patients: a retrospective cohort analysis.
Thromb J
; 18: 6, 2020.
Artículo
en Inglés
| MEDLINE | ID: mdl-32292291
5.
Comparative effectiveness, safety, and costs of rivaroxaban and warfarin among morbidly obese patients with atrial fibrillation.
Am Heart J
; 212: 113-119, 2019 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-30981035
6.
Evaluation of clinical outcomes among nonvalvular atrial fibrillation patients treated with rivaroxaban or warfarin, stratified by renal functionâ©.
Clin Nephrol
; 89(5): 314-329, 2018 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-29231162
7.
Shortened hospital length of stay and lower costs associated with rivaroxaban in patients with pulmonary embolism managed as observation status.
Int J Clin Pract
; 71(1)2017 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-28097761
8.
Observation management of pulmonary embolism and agreement with claims-based and clinical risk stratification criteria in United States patients: a retrospective analysis.
BMC Pulm Med
; 17(1): 37, 2017 Feb 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-28193193
9.
Outcomes associated with observation stays versus inpatient admissions for pulmonary embolism.
J Thromb Thrombolysis
; 42(4): 513-9, 2016 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-27324143
10.
Response to letter regarding article "Rivaroxaban versus warfarin in patients with nonvalvular atrial fibrillation and stage IV-V chronic kidney disease".
Am Heart J
; 223: 111-112, 2020 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-32386598
11.
Assessment of clinical and economic impactâ¯of rivaroxaban plus aspirin vs. aspirin alone as a secondary prophylaxis in patients with chronic and symptomatic peripheral arterial disease in the United States.
J Med Econ
; 27(1): 10-15, 2024.
Artículo
en Inglés
| MEDLINE | ID: mdl-38044632
12.
Prediction of cardiovascular and renal risk among patients with apparent treatment-resistant hypertension in the United States using machine learning methods.
J Clin Hypertens (Greenwich)
; 26(5): 500-513, 2024 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-38523465
13.
Real-World Impact of Blood Pressure Control in Patients With Apparent Treatment-Resistant or Difficult-to-Control Hypertension and Stages 3 and 4 Chronic Kidney Disease.
Am J Hypertens
; 37(6): 438-446, 2024 May 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-38436491
14.
Association of uncontrolled blood pressure in apparent treatment-resistant hypertension with increased risk of major adverse cardiovascular events plus.
J Clin Hypertens (Greenwich)
; 25(8): 737-747, 2023 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-37461262
15.
Effectiveness and Safety of Rivaroxaban Versus Warfarin among Nonvalvular Atrial Fibrillation Patients with Concomitant Obstructive Sleep Apnea.
TH Open
; 7(1): e82-e93, 2023 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-37009629
16.
Healthcare Resource Utilization and Costs of Rivaroxaban Versus Warfarin Among Non-valvular Atrial Fibrillation (NVAF) Patients with Diabetes in a US Population.
Adv Ther
; 40(3): 1224-1241, 2023 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-36658454
17.
Comparative outcomes associated with rivaroxaban versus warfarin use in elderly patients with atrial fibrillation or acute venous thromboembolism managed in the United States: a systematic review of observational studies.
Curr Med Res Opin
; 39(9): 1183-1194, 2023 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-37584187
18.
Adherence and persistence to rivaroxaban in non-valvular atrial fibrillation patients receiving 30- or 90-day supply prescription fills.
Curr Med Res Opin
; 38(1): 19-26, 2022 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34581258
19.
Risk factors for recurrent venous thromboembolism: a real-world analysis.
Blood Coagul Fibrinolysis
; 33(6): 301-309, 2022 Sep 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-35834716
20.
Effectiveness and Safety of Rivaroxaban versus Warfarin Among Nonvalvular Atrial Fibrillation Patients with Obesity and Polypharmacy.
Am J Cardiovasc Drugs
; 22(4): 425-436, 2022 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-35092000